PA

Perceptive Advisors Portfolio holdings

AUM $2.67B
This Quarter Return
+65.17%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$5B
AUM Growth
+$5B
Cap. Flow
-$50.5M
Cap. Flow %
-1.01%
Top 10 Hldgs %
53.97%
Holding
139
New
30
Increased
24
Reduced
18
Closed
23

Top Buys

1
KRRO icon
Korro Bio
KRRO
$49.8M
2
AGIO icon
Agios Pharmaceuticals
AGIO
$43M
3
KOD icon
Kodiak Sciences
KOD
$38M
4
PRVB
Provention Bio, Inc. Common Stock
PRVB
$33.6M
5
QTNT
Quotient Limited Ordinary Shares
QTNT
$23.8M

Top Sells

1
DOVA
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$104M
2
SLDB icon
Solid Biosciences
SLDB
$69.8M
3
NBIX icon
Neurocrine Biosciences
NBIX
$48.1M
4
IOVA icon
Iovance Biotherapeutics
IOVA
$44.2M
5
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
$33.9M

Sector Composition

1 Healthcare 95.76%
2 Financials 0.38%
3 Technology 0.12%
4 Consumer Discretionary 0.04%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ADMA icon
26
ADMA Biologics
ADMA
$4.03B
$46.1M 0.92%
11,521,102
– –
PRVB
27
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$43.5M 0.86%
2,921,574
+2,255,252
+338% +$33.6M
ALBO
28
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$43.3M 0.86%
1,704,330
– –
ARNA
29
DELISTED
Arena Pharmaceuticals Inc
ARNA
$43.3M 0.86%
953,129
– –
AGIO icon
30
Agios Pharmaceuticals
AGIO
$2.36B
$43M 0.85%
+900,000
New +$43M
TVTX icon
31
Travere Therapeutics
TVTX
$1.75B
$41M 0.82%
2,890,608
-379,963
-12% -$5.4M
ALLO icon
32
Allogene Therapeutics
ALLO
$249M
$40.1M 0.8%
1,543,790
– –
EIDX
33
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$40M 0.8%
697,524
+10,532
+2% +$604K
UROV
34
DELISTED
Urovant Sciences Ltd.
UROV
$37.3M 0.74%
2,406,931
+160,384
+7% +$2.49M
FOMX
35
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$37.3M 0.74%
11,203,881
– –
NEPT
36
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$36.8M 0.73%
9,598
– –
MTEM
37
DELISTED
Molecular Templates, Inc.
MTEM
$34.6M 0.69%
164,942
+33,333
+25% +$6.99M
AGRX
38
DELISTED
Agile Therapeutics, Inc
AGRX
$29.8M 0.59%
5,960
+597
+11% +$2.98M
ESTA icon
39
Establishment Labs
ESTA
$1.11B
$29.1M 0.58%
1,050,528
-210,000
-17% -$5.81M
TPTX
40
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$27.2M 0.54%
437,390
-159,800
-27% -$9.95M
CTMX icon
41
CytomX Therapeutics
CTMX
$350M
$27M 0.54%
3,253,923
– –
BIO icon
42
Bio-Rad Laboratories Class A
BIO
$7.8B
$25.3M 0.5%
68,489
+3,489
+5% +$1.29M
RGNX icon
43
Regenxbio
RGNX
$498M
$24.9M 0.49%
608,000
– –
VAPO
44
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$21.2M 0.42%
217,971
-2,588
-1% -$252K
CNCE
45
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$19.8M 0.39%
2,150,641
-44,000
-2% -$406K
STOK icon
46
Stoke Therapeutics
STOK
$1.08B
$19M 0.38%
671,978
– –
EHTH icon
47
eHealth
EHTH
$126M
$19M 0.38%
197,720
-57,369
-22% -$5.51M
TNDM icon
48
Tandem Diabetes Care
TNDM
$834M
$18.5M 0.37%
310,000
+303,578
+4,727% +$18.1M
ALDX icon
49
Aldeyra Therapeutics
ALDX
$350M
$17.9M 0.36%
3,085,458
– –
YMAB icon
50
Y-mAbs Therapeutics
YMAB
$390M
$17.6M 0.35%
562,237
-292,703
-34% -$9.15M
1
2
3 4 5